Protocol No.: S2107

Title
Randomized Phase II trial of encorafenib and cetuximab with or without nivolumab (NSC #748726) for patients with previously treated, microsatellite stable, BRAFV600E metastatic and/or unresectable colorectal cancer
Principal Investigator
Daboul, Nour
Phase
II
Age Group
Adult
Applicable Disease Site
Gastrointestinal Cancers
Participating Institutions
Mary Babb Randolph Cancer Center
United Hospital Center
Contacts
Sabrina Rexroad, RN
Research Nurse
Phone: +1 304-293-6066
Nnennaya Opara
Clinical Research Specialist
Phone: +1 681-342-1000

View on ClinicalTrials.gov